v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - ARS ($)
$ in Millions
Equity attributable to controlling company
Outstanding shares, Capital nominal value
 [1]
Inflation adjustment
Contributed Surplus
Legal
Special reserve for IFRS implementation
Facultative
 [2]
Other comprehensive results
Retained earnings
Equity attributable to non- controlling interest
Credipay
 [6]
Equity attributable to non- controlling interest
Credipay
 [6]
Total
Beginning balances at Dec. 31, 2021 $ 8,720,971 $ 2,154 $ 2,281,597 $ 5,866,367 $ 128,917 $ 49,683 $ 483,184 $ (229,410) $ 138,479   $ 138,103   $ 8,859,074
Resolutions of the General Extraordinary Shareholders' Meeting held on                          
- Reserves constitution         6,584   133,011   (139,595)        
- Reserves reallocation       (246,298)     246,298            
- Dividends [3] (374,325)           (374,325)           (374,325)
Dividends to non-controlling shareholders [3]               (1,116) 1,116   (10,510)   (10,510)
Comprehensive income:                          
Net income (loss) for the year (1,718,966)               (1,718,966)   18,137   (1,700,829)
Other comprehensive income (loss) (41,232)             (41,232)     (11,644)   (52,876)
Total comprehensive income (loss) for the year (1,760,198)             (41,232) (1,718,966)   6,493   (1,753,705)
Ending balances at Dec. 31, 2022 6,586,448 2,154 2,281,597 5,620,069 135,501 49,683 488,168 (271,758) (1,718,966)   134,086   6,720,534
Resolutions of the General Extraordinary Shareholders' Meeting held on                          
- Absorption of retained earnings (losses) and reserve reclassification       (84,257)         257,730        
- Reserves constitution             546,655   (546,655)        
- Specific loss allocation       (2,265,621)         2,265,621        
- Dividends [3] (277,404)           (277,404)           (277,404)
Dividends to non-controlling shareholders [3]                     (10,677)   (10,677)
Subsidiary acquisition [4]                     (5)   (5)
Subsidiary call option [5] (1,567)             (1,567)         (1,567)
Comprehensive income:                          
Net income (loss) for the year (684,523)               (684,523)   21,362   (663,161)
Other comprehensive income (loss) 134,865             134,865     61,206   196,071
Total comprehensive income (loss) for the year (549,658)             134,865 (684,523)   82,568   (467,090)
Ending balances at Dec. 31, 2023 5,757,819 2,154 2,281,597 3,354,448 135,501 49,683 757,419 (138,460) (684,523)   205,972   5,963,791
Resolutions of the General Extraordinary Shareholders' Meeting held on                          
- Absorption of retained earnings (losses) and reserve reclassification [1]       (205,624)     (478,899)   684,523        
- Dividends [3] (144,962)           (144,962)           (144,962)
Dividends to non-controlling shareholders [3]                     (12,720)   (12,720)
Subsidiary acquisition                   $ 788 2,297 [7] $ 788 2,297 [7]
Transaction non-controlling interest [8] (32,080)             (32,080)     (3,035)   (35,115)
Comprehensive income:                          
Net income (loss) for the year 1,234,786               1,234,786   25,427   1,260,213
Other comprehensive income (loss) (198,916)             (198,916)     (84,836)   (283,752)
Total comprehensive income (loss) for the year 1,035,870             (198,916) 1,234,786   (59,409)   976,461
Ending balances at Dec. 31, 2024 $ 6,616,647 $ 2,154 $ 2,281,597 $ 3,148,824 $ 135,501 $ 49,683 $ 133,558 $ (369,456) $ 1,234,786   $ 133,893   $ 6,750,540
[1] See Note 21.
[2] Corresponds to the Facultative Reserve to maintain the capital investments level and the current level of solvency.
[3] See Note 4.b).
[4] Correspond to Ubiquo’s acquisition. See Note 1.b).
[5] This operation represents a transaction between controlling and non-controlling stockholders related to the extension of the purchase option of Adesol’s special purpose entities. Therefore. the payments made by the subsidiary Adesol were recognized directly in “Other comprehensive income (loss)” within equity attributable to controlling company.
[6] Correspond to the establish of a new company, CrediPay. See Note 1.b).
[7] Corresponds to the exercise of the Naperville call option. See Note 28.2.1.
[8] See Note 28.2.2.